ARBORI-GENE financials
A multi-period view of the public annual-account figures reported for ARBORI-GENE, with comparable measures and links to available source documents.
Company overviewRegistry number
0827641216
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for ARBORI-GENE
2025 versus 2024
- Operating line
- €39,867
- EBITDA
- €39,867
- Total assets
- €145,599
- Equity
- €90,500
+6.4%
+6.4%
-10.7%
+5.2%
EBITDA margin +100% · Equity ratio +62.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €39,867 | €39,867 | €145,599 | €90,500 | - |
| 202431 Dec 2024 | €37,455 | €37,455 | €162,957 | €86,038 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.